238 related articles for article (PubMed ID: 6644306)
1. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
Lerer B; Stanley M; Demetriou S; Gershon S
J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
[TBL] [Abstract][Full Text] [Related]
2. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
Lerer B
Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
[TBL] [Abstract][Full Text] [Related]
3. Effect of electroconvulsive shock on central cholinergic (muscarinic) receptors.
Gulati A; Nath C; Dhawan KN; Bhargava KP; Agarwal AK; Seth PK
Brain Res; 1982 May; 240(2):357-8. PubMed ID: 7104697
[TBL] [Abstract][Full Text] [Related]
4. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
Adem A; Sabbagh M; Nordberg A
J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
[TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment.
Westlind A; Grynfarb M; Hedlund B; Bartfai T; Fuxe K
Brain Res; 1981 Nov; 225(1):131-41. PubMed ID: 7296273
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive shock and brain muscarinic receptors: relationship to anterograde amnesia.
Lerer B; Stanley M; McIntyre I; Altman H
Life Sci; 1984 Dec; 35(26):2659-64. PubMed ID: 6513731
[TBL] [Abstract][Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
9. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
10. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
11. Repeated noise exposure affects muscarinic cholinergic receptors in the rat brain.
Lai H; Carino MA; Wen YF
Brain Res; 1989 May; 488(1-2):361-4. PubMed ID: 2743133
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
15. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
17. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
[TBL] [Abstract][Full Text] [Related]
18. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
19. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
[TBL] [Abstract][Full Text] [Related]
20. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
Hruska RE; Ludmer LM; Pert A; Bunney WE
J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
